Article
Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
Pediatric research - 1 Aug 2016
Nomura Akitaka, Maruo Yoshihiro, Taga Takashi, Takeuchi Yoshihiro
Abstract excerpt
BACKGROUND: Chemotherapy for malignant neoplasms sometimes induces unconjugated hyperbilirubinemia, resulting in the early cessation of treatment. We evaluated the role of variations in the bilirubin uridine-5-diphosphate (UDP)-glucuronosyltransferase gene (UGT1A1) in unconjugated hyperbilirubinemia development during chemotherapy in pediatric patients with leukemia. METHODS: UGT1A1 allelic variations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
